Related Experiment Videos
Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with
Insights
This study investigated cardiac venous system interventions for reducing myocardial infarct size in dogs. Arteriovenous shunts showed potential for protecting heart tissue during coronary occlusion.
Area of Science:
- Cardiovascular Research
- Myocardial Protection Strategies
- Interventional Cardiology
Background:
- Myocardial infarct size can be reduced by interventions delivering arterial blood retrogradely via cardiac veins.
- Alternatively, interventions involve intermittent occlusion of the cardiac venous system.
Purpose of the Study:
- To compare various myocardial protection modalities utilizing the cardiac venous system.
- To quantitatively measure infarct size and assess the efficacy of different interventions.
Main Methods:
- 73 dogs underwent coronary arterial occlusion and were randomized into seven groups.
- Interventions included venovenous shunts, arteriovenous shunts (varying flow and location), and cardiac vein occlusion.
- Infarct size and hypoperfused zone (area at risk) were assessed using 99mTc-labeled albumin microspheres.
Main Results:
- The study compared seven groups, including a control group with no intervention.
- Different arteriovenous shunt configurations and venovenous shunts were tested.
- Quantitative measurement of infarct size was performed to evaluate intervention effectiveness.
Conclusions:
- The study provides a quantitative comparison of cardiac venous system interventions for myocardial protection.
- Findings contribute to understanding strategies for reducing infarct size in ischemic heart conditions.
Abstract:
It has been reported that infarct size can be reduced by several interventions, by which arterial blood is delivered retrogradely to the ischemic myocardium through the cardiac veins or alternatively the cardiac venous system is intermittently occluded. Accordingly, we studied several modalities of myocardial protection that used the cardiac venous system and compared them by means of a quantitative technique for measuring infarct size. Thus 73 anesthetized dogs with coronary arterial occlusion were randomized into the following groups: group I (n = 9), 6 hr of occlusion without any intervention; group II (n = 11), venovenous shunt (60 ml/min) to the great cardiac vein; group III (n = 11), arteriovenous shunt to the anterior interventricular vein; group IV (n = 12), high flow arteriovenous shunt to the anterior interventricular vein (60 ml/min); group V (n = 11), arteriovenous shunt to the great cardiac vein (60 ml/min); group VI (n = 10), arteriovenous shunt to the great cardiac vein (60 ml/min) combined with diastolic occlusion of the great cardiac vein; group VII (n = 9), intermittent pressure-controlled occlusion of the great cardiac vein without arterialization. The arteriovenous shunt (groups III to VI) or venovenous shunt (group II) was done by selective catheterization of the anterior interventricular vein or the great cardiac vein, advancing a catheter from the jugular vein through the right atrium and coronary sinus under fluoroscopic control. This catheter was then connected to a cannula located either in the carotid artery (groups III to VI) or in the right atrium (group II). One minute after occlusion, 99mTc-labeled albumin microspheres (8 mCi) were injected into the left atrium for the subsequent assessment of the hypoperfused zone, which is the area at risk for infarction.(ABSTRACT TRUNCATED AT 250 WORDS)